- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 125, Issue 8, Pages 773-782
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-09-03
DOI
10.1161/circresaha.119.315380
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetically Determined Levels of Circulating Cytokines and Risk of Stroke
- (2019) Marios K. Georgakis et al. CIRCULATION
- Anticytokine Agents
- (2019) Paul M Ridker CIRCULATION RESEARCH
- Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis
- (2018) Carla Winter et al. Cell Metabolism
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. EUROPEAN HEART JOURNAL
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
- (2018) Peter Willeit et al. LANCET
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of coronary artery disease: discovery, biology and clinical translation
- (2017) Amit V. Khera et al. NATURE REVIEWS GENETICS
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
- (2017) Ilze Bot et al. Scientific Reports
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Nicholas J Kassebaum et al. LANCET
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
- (2016) Charles C. Esenwa et al. Nature Reviews Neurology
- Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study
- (2016) Ashkan Shoamanesh et al. NEUROLOGY
- Associations Between Macrophage Colony‐Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First‐Time Coronary Events: A Nested Case–Control Study
- (2016) Alexandru Schiopu et al. Journal of the American Heart Association
- Impact of MCP -1 in Atherosclerosis
- (2014) Juntang Lin et al. CURRENT PHARMACEUTICAL DESIGN
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- A Novel C^|^#8211;C Chemokine Receptor 2 Antagonist Prevents Progression of Albuminuria and Atherosclerosis in Mouse Models
- (2012) Masayuki Okamoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
- (2011) Jim Gilbert et al. AMERICAN JOURNAL OF CARDIOLOGY
- Chemokine Ligand 2 Genetic Variants, Serum Monocyte Chemoattractant Protein-1 Levels, and the Risk of Coronary Artery Disease
- (2010) Diederik F. van Wijk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A New Monocyte Chemotactic Protein-1/Chemokine CC Motif Ligand-2 Competitor Limiting Neointima Formation and Myocardial Ischemia/Reperfusion Injury in Mice
- (2010) Elisa A. Liehn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice
- (2008) Christophe Combadière et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started